TCT 220: Real-world Utilization of PASCAL Precision System in non-A2P2 Degenerative Mitral Regurgitation

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Medtronic</li><li>Equity/Stock(s)/Options - ValCor Cath Inc.</li><li> - ValCor Cath inc</li></ul>